Zydus Wellness
Market cap ₹14,527 Cr
- P/E
- 58.99
- Day range
- ₹455.45 – ₹464.20
- 52-week range
- ₹367.55 – ₹611.85
- Volume
- 55,448
- Open
- ₹462.65
- Prev close
- ₹460.35
Latest results · Q2 FY27(consolidated)Revenue ₹1,127 Cr+73.2%Profit ₹5 CrMargin 0.5%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
ZYDUSWELL in NSE indices and F&O
Research profile
Composite 44 / 100Factor percentiles
Derived metrics
- Earn. yield
- 1.7%
- Graham no.
- ₹181.04
- vs Graham
- -60.3%
- ROE ÷ P/B
- 1.4%
- 12-1 mom.
- +13.2%
- Return / vol
- 0.06
- Magic Formula
- #587
- Piotroski
- 3/6
- FCF yield
- 0.9%
Appears in 7 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 45 in FMCG| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Hindustan UnileverHINDUNILVR | ₹4.68 L Cr | 44.25 | 9.58 | 30.7% | 28.0% | 22.0% | 0.03 | +14.5% |
| ITCITC | ₹3.72 L Cr | 19.68 | 5.18 | 29.5% | 39.0% | 28.0% | 0.01 | +3.9% |
| Nestle IndiaNESTLEIND | ₹2.47 L Cr | 60.60 | 43.23 | 76.3% | 85.0% | 24.0% | 0.08 | +20.3% |
| Varun BeveragesVBL | ₹1.44 L Cr | 146.90 | 7.43 | 16.9% | 20.0% | 22.0% | 0.13 | +33.2% |
| MaricoMARICO | ₹1.18 L Cr | 58.23 | 25.11 | 44.3% | 47.0% | 18.0% | 0.26 | +13.0% |
| Britannia IndustriesBRITANNIA | ₹1.13 L Cr | 42.15 | 26.99 | 53.6% | 56.0% | 18.0% | 0.62 | +15.6% |
| Tata Consumer ProductsTATACONSUM | ₹1.12 L Cr | 65.86 | 4.99 | 7.4% | 9.0% | 14.0% | 0.11 | +14.0% |
| Zydus WellnessZYDUSWELL | ₹14,527 Cr | 58.99 | 2.47 | 3.4% | 5.0% | 7.6% | 0.54 | +73.2% |
| Sector median | ₹14,559 Cr | 34.44 | 5.48 | 18.1% | 19.0% | 15.0% | 0.20 | +14.8% |
Sector as classified in the tracked universe; medians use every tracked FMCG company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 5h agoHeadlines about Zydus Wellness from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 58.3
- Price / Book
- 2.45
- ROE (FY26)
- 3.4%
- ROCE (latest year)
- 5%
- Dividend yield
- 0.26%
Moving averages (NSE)
- 20-day
- ₹475.52
- Price below
- 50-day
- ₹504.14
- Price below
- 200-day
- ₹493.26
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- DII
- Public
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date. Not adjusted for the split of 18 Sept 2025: earlier bars are per pre-split share.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 403.20 | 782.60 | 841 | 492.90 | 461.90 | 913.10 | 860.90 | 650.50 | 964.90 | 1,484.70 | 1,437 | 1,126.60 |
| YoY Sales growth | -3.17 | — | — | — | — | — | — | — | — | — | — | — |
| Expenses | 390.50 | 620.40 | 685.70 | 473.30 | 447.10 | 723.10 | 705.30 | 627.50 | 903.90 | 1,214.60 | 1,195.30 | 1,041.10 |
| Operating Profit | 12.70 | 162.20 | 155.30 | 19.60 | 14.80 | 190 | 155.60 | 23 | 61 | 270.10 | 241.70 | 85.50 |
| OPM % | 3.1% | 20.7% | 18.5% | 4.0% | 3.2% | 20.8% | 18.1% | 3.5% | 6.3% | 18.2% | 16.8% | 7.6% |
| Other Income | 3.40 | 4 | 5 | 9.90 | 3.80 | 0.80 | 3 | -32.80 | -5.80 | 1.20 | 3.80 | 6.40 |
| Interest | 6.30 | 6.10 | 3.60 | 0.90 | 3.30 | 4.20 | 2.50 | 15.70 | 41.20 | 38.70 | 26.30 | 27.20 |
| Depreciation | 6.10 | 5.70 | 5.10 | 4.90 | 5.20 | 13.20 | 10.80 | 25.10 | 55.50 | 55.30 | 57.10 | 57.10 |
| Profit before tax | 3.70 | 154.40 | 151.60 | 23.70 | 10.10 | 173.40 | 145.30 | -50.60 | -41.50 | 177.30 | 162.10 | 7.60 |
| Tax % | 91.9% | 2.7% | 2.6% | 11.8% | 36.6% | 0.9% | 12.0% | 4.3% | -3.9% | 8.6% | 26.6% | 32.9% |
| Net Profit | 0.30 | 150.30 | 147.70 | 20.90 | 6.40 | 171.90 | 127.90 | -52.80 | -39.90 | 162 | 118.90 | 5.10 |
| EPS in Rs | ₹0.01 | ₹4.72 | ₹4.64 | ₹0.66 | ₹0.20 | ₹5.40 | ₹4.02 | ₹-1.66 | ₹-1.25 | ₹5.09 | ₹3.74 | ₹0.16 |
From company filings, updated 18 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
+17 days since Mar 2021
+20 days since Mar 2021
-82 days since Mar 2021
+119 days since Mar 2021
+83 days since Mar 2021
Strengths, risks & growth
Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)
Strengths
- Company is expected to give good quarter
Risks
- Company has a low return on equity of 5.09% over last 3 years.
- Dividend payout has been low at 14.1% of profits over last 3 years
Compounded Sales Growth
- 10 Years
- +26%
- 5 Years
- +16%
- 3 Years
- +21%
- TTM
- +74%
Compounded Profit Growth
- 10 Years
- +8%
- 5 Years
- -2%
- 3 Years
- -10%
- TTM
- -11%
Stock Price CAGR
- 10 Years
- +10%
- 5 Years
- +3%
- 3 Years
- +14%
- 1 Year
- +1%
Return on Equity
- 10 Years
- +6%
- 5 Years
- +6%
- 3 Years
- +5%
- Last Year
- +4%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 69.64% | 69.64% | 69.63% | 69.63% | 0.00 pp |
| FII | 3.27% | 3.17% | 3.32% | 3.57% | +0.25 pp |
| DII | 18.58% | 18.87% | 19.13% | 19.39% | +0.26 pp |
| Public | 8.51% | 8.32% | 7.92% | 7.42% | -0.50 pp |
Filed with NSE for Sept 2026: promoters 69.64%, public 30.36%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 18.72% (-0.01 pp)- Promoters69.6%
- Foreign institutions3.6%
- Mutual funds18.7%
- Insurance0.6%
- Other domestic institutions0.1%
- Retail5.2%
- Others2.2%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| Parag Parikh Flexi Cap Fund | 6.92% | 0.70% | -0.16 pp |
| Nippon India Small Cap Fund | 5.41% | 1.03% | -0.22 pp |
| Quant Small Cap Fund | 2.84% | 1.23% | -0.30 pp |
| Quant Multi Cap Fund | 0.55% | 1.08% | -0.18 pp |
| Bajaj Finserv Small Cap Fund | 0.51% | 2.69% | -0.33 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 291 daily sessions to 17 Nov 2026. Adjusted for 1 corporate action.
Risk
- Volatility (1Y)
- 38.1%
- Downside volatility
- 34.0%
- Worst 5% of days
- 3.6%
- Average of that tail
- 4.3%
- Max drawdown (1Y)
- 28.8%
- Below its peak
- 23.6%
Against the market
- Beta vs Nifty 50
- 0.54
- Correlation
- 0.19
- Relative strength (3M)
- -14.0%
- ATR (14)
- 4.0%
Return
- Return 1M
- -9.7%
- Return 3M
- -9.8%
- Return 6M
- -8.3%
- Return 1Y
- +2.2%
- vs 200-day average
- -6.7%
Momentum
- RSI (14)
- 39.3
- MACD histogram
- 0.07
- Stochastic %K
- 6.1
- ADX (14)
- 17.0
- +DI / −DI
- 15.0 / 20.4
- Money flow index
- 77.4
Participation
- Delivery (20d avg)
- 41.0%
- vs its 60-day baseline
- -1.7 pts
- Volume vs 20-day
- -0.3σ
- Close vs day's VWAP
- -0.5%
- 52-week position
- 38 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
3 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — failed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — failed
- Current ratio improving — passed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — failed
- Asset turnover improving — passed
- Free cash flow
- ₹125 Cr
- FCF yield
- 0.9%
- Cash conversion
- 1.15
- Accruals ratio
- -0.003
- Net debt
- ₹3,131 Cr
- Net debt / equity
- 0.53
- EV / sales
- 3.55
- Capex intensity
- 2.6%
- Revenue CAGR
- 15.0%
- Profit CAGR
- -90.4%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
Prashant Babubhai Patel Promoter Group · Off Market | Buy | 27,250 | ₹0 | 24 Aug 2026 |
Rinesh Gajjar Employees/Designated Employees · Market Purchase | Buy | 1,500 | ₹6.0 L | 18 Mar 2026 |
Rajat Bhargava Employees/Designated Employees · Market Purchase | Buy | 750 | ₹2.9 L | 9 Mar 2026 |
Vineet Shrivastava Employees/Designated Employees · Market Purchase | Buy | 787 | ₹3.0 L | 9 Mar 2026 |
Yatin Desai Employees/Designated Employees · Market Purchase | Buy | 500 | ₹1.9 L | 9 Mar 2026 |
Punit Adhia Employees/Designated Employees · Market Purchase | Buy | 300 | ₹1.1 L | 6 Mar 2026 |
Umesh Vinodray Parikh Key Managerial Personnel · Market Purchase | Buy | 250 | ₹95,019 | 3 Mar 2026 |
Vineet Shrivastava Employees/Designated Employees · Market Purchase | Buy | 507 | ₹2.0 L | 2 Mar 2026 |
Umesh Vinodray Parikh Employees/Designated Employees · Market Purchase | Buy | 6,225 | ₹25.0 L | 17 Feb 2026 |
Tarun G Arora Employees/Designated Employees · Market Purchase | Buy | 4,000 | ₹16.3 L | 16 Feb 2026 |
Nidhi Punit Adhia Employees/Designated Employees · Market Purchase | Buy | 1,000 | ₹3.9 L | 10 Feb 2026 |
Dhaval Narendra Soni HUF Other · Market Sale | Sell | 250 | ₹1.0 L | 9 Dec 2025 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
- dividendNot available — not reported in this filing
Dividend - Re 1.20 Per Share
17 Jul 2026ex-date - splitNot available — not reported in this filing
Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
18 Sept 2025ex-date - dividend₹6.00
Dividend - Rs 6 Per Share
11 Jul 2025ex-date - dividend₹5.00
Dividend - Rs 5 Per Share
19 Jul 2024ex-date - dividend₹5.00
Dividend - Rs 5 Per Share
21 Jul 2023ex-date - dividend₹5.00
Dividend - Rs 5 Per Share
14 Jul 2022ex-date - dividend₹5.00
Annual General Meeting/Dividend - Rs 5 Per Share
14 Jul 2021ex-date - otherNot available — not reported in this filing
Annual General Meeting
12 Aug 2020ex-date - dividend₹5.00
Interim Dividend - Rs 5 Per Share
19 Mar 2020ex-date - dividend₹5.00
Dividend - Rs 5 Per Share
17 Jul 2019ex-date - dividend₹8.00
Dividend- Rs 8 Per Share
18 Jul 2018ex-date - otherNot available — not reported in this filing
Annual General Meeting
27 Jul 2017ex-date - dividendNot available — not reported in this filing
Interim Dividend Re 6.50 Per Share (Purpose Revised)
9 Mar 2017ex-date - otherNot available — not reported in this filing
Annual General Meeting
21 Jul 2016ex-date - dividend₹6.50
Interim Dividend - Rs 6.50/- Per Share
16 Mar 2016ex-date - dividend₹6.00
Annual General Meeting/Dividend - Rs 6/- Per Share
16 Jul 2015ex-date - dividend₹6.00
Annual General Meeting / Dividend - Rs 6/- Per Share
3 Jul 2014ex-date - otherNot available — not reported in this filing
Annual General Meeting
22 Jul 2013ex-date - dividend₹6.00
Interim Dividend @ Rs. 6/- Per Equity Share
22 May 2013ex-date - dividend₹5.00
Annual General Meeting/Dividend Rs 5 Per Share
18 Jul 2012ex-date
Company announcements
Newspaper publication
Trading Window Closure for the quarter and half year ending on September 30, 2026
Change in Senior Management Personnel
Clarification on volume movement
The Exchange has sought clarification from Zydus Wellness Ltd on September 8, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
ESG rating assigned by SES
Analyst / Institutional Investors' Conference on September 22, 2026
Transcript of 32nd Annual General Meeting
Appointment of Mr. Kapil Sharma as Chief Revenue Officer forming part of Senior Management of the Company
Disclosure under SEBI (PIT) Regulations, 2015
Credit rating assigned by Care Ratings Limited
Transcript of the Earnings Conference call held on August 4, 2026
ESG rating received from Crisil
Schedule of Analyst / Institutional Investors' Conference to be held on August 14, 2026
Newspaper publication regarding unaudited financial results for the quarter ended on June 30, 2026
Filed with BSE (scrip 531335); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- May 2026TranscriptSlidesRecording
- Mar 2026Slides
- Mar 2026Slides
- Feb 2026TranscriptSlidesRecording
Credit ratings
- Rating update · 19 Nov 2020 from crisil
- Rating update · 29 Oct 2020 from care
- Rating update · 8 Oct 2020 from crisil
- Rating update · 10 Aug 2020 from crisil
- Rating update · 2 Jan 2020 from care
- Rating update · 24 Dec 2019 from crisil
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 3 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Zydus Wellness: common questions
Answered from the figures on this page.